Koninklijke Philips (PHG)
(Delayed Data from NYSE)
$26.88 USD
+0.06 (0.22%)
Updated May 6, 2024 04:00 PM ET
After-Market: $26.90 +0.02 (0.07%) 7:58 PM ET
4-Sell of 5 4
B Value B Growth B Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
PHG 26.88 +0.06(0.22%)
Will PHG be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for PHG based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PHG
Philips (PHG) Q1 Earnings Beat Estimates, Revenues Fall Y/Y
Philips (PHG) Receives FDA Warning Letter Regarding CT Systems
PHG: What are Zacks experts saying now?
Zacks Private Portfolio Services
Philips' (PHG) Zenition 30 to Boost Image-Guided Surgeries
Philips (PHG) Agrees to a Consent Decree With DOJ and FDA
Philips (PHG) Boosts Patient Monitoring With smartQare Deal
Other News for PHG
Will Earnings Cheer Continue This Week? All Eyes On Disney, Palantir, Robinhood While Reddit Gears Up For Debut Quarterly Report
Oppenheimer Remains a Buy on Pharming Group (PHAR)
Koninklijke Philips: Major Overhang Removed
Nicklaus Children’s Health System, Philips to provide innovative patient and staff experience, helping to enhance outcomes for the smallest of patients
Philips enters 10-year collaboration with Nicklaus Children's Health System